CHRISTINA LAKE CANNABIS - Asset Resilience Ratio
CHRISTINA LAKE CANNABIS (CLB) has an Asset Resilience Ratio of 0.19% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CLB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how CHRISTINA LAKE CANNABIS's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CHRISTINA LAKE CANNABIS balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down CHRISTINA LAKE CANNABIS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CHRISTINA LAKE CANNABIS total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €52.31K | 0.19% |
| Total Liquid Assets | €52.31K | 0.19% |
Asset Resilience Insights
- Limited Liquidity: CHRISTINA LAKE CANNABIS maintains only 0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CHRISTINA LAKE CANNABIS Industry Peers by Asset Resilience Ratio
Compare CHRISTINA LAKE CANNABIS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Dr. Reddy's Laboratories Limited
F:RDDA |
Drug Manufacturers - Specialty & Generic | 11.36% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 48.48% |
|
Apeloa Pharmaceutical Co Ltd
SHE:000739 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.35% |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
Drug Manufacturers - Specialty & Generic | 0.66% |
Annual Asset Resilience Ratio for CHRISTINA LAKE CANNABIS (2021–2024)
The table below shows the annual Asset Resilience Ratio data for CHRISTINA LAKE CANNABIS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-11-30 | 0.21% | €50.00K ≈ $58.46K |
€23.37 Million ≈ $27.32 Million |
-- |
| 2023-11-30 | 0.00% | €0.00 ≈ $0.00 |
€15.96 Million ≈ $18.66 Million |
-- |
| 2022-11-30 | 0.15% | €28.75K ≈ $33.61K |
€18.79 Million ≈ $21.97 Million |
+0.00pp |
| 2021-11-30 | 0.15% | €28.75K ≈ $33.61K |
€19.04 Million ≈ $22.26 Million |
-- |
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more